Toward an effective TB vaccine: Analysis of the immune response to a promising candidate

BCG, the only currently approved TB vaccine, is only partially effective. Given the complicated TB treatment, the rise of adult TB cases in conjunction with the HIV epidemic, and increasing multidrug-resistant TB strains, a new and better vaccine is a global health priority. A new study dissects the immune response in mice to an experimental vaccine and shows why it is highly effective.